FDA limits approval for new coronavirus vaccines to high risk people The Washington PostF.D.A. Approves Covid Shots With New Restrictions The New York TimesRFK Jr. limits who is eligible for COVID shots AxiosThe latest COVID vaccines come with new FDA limits NPRPfizer and BioNTech’s COMIRNATY® Receives U.S. FDA Approval for Adults 65 and Older and Individuals Ages 5 through 64 at Increased Risk for Severe COVID-19 Business Wire